News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No news articles were published in the past hour, leaving market-moving headlines absent.
  • No major economic data or central bank comments were released in the past hour.
  • No significant corporate earnings or M&A announcements arrived to shift stock sentiment.
  • No new geopolitical or crisis developments were reported that could drive risk-off flows.
  • Commodity and Treasury markets lacked fresh catalysts amid the quiet news flow.
  • Markets will likely remain range-bound until fresh headlines or scheduled data arrive later.

Latest Articles

DeFi Development Corp. Reports Q2 2026 Results, Grows SOL Per Share 24% Year Over Year, Outlines Q3 Cost Efficiencies and Capital Structure Simplification

DeFi Development Corp. Reports Q2 2026 Results, Grows SOL Per Share 24% Year Over Year, Outlines Q3 Cost Efficiencies and Capital Structure Simplification

DeFi Development Corp. disclosed a 24% year-over-year increase in SOL per share, reaching 0.066 as of August 12, 2026. The company announced operational efficiencies to reduce costs in Q3 and beyond, repurchased convertible notes at a discount to simplify capital structure, and reaffirmed its long-term target to achieve 1.0 SOL per share by Decembe…

Ryman Hospitality Properties, Inc. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Over-Allotment Option

Ryman Hospitality Properties, Inc. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Over-Allotment Option

Ryman Hospitality Properties, Inc. announced the successful closing of an underwritten common stock offering totaling 5,865,000 shares priced at $117 each, including full exercise of the underwriters' over-allotment option, raising net proceeds of approximately $658 million. The proceeds will be contributed to RHP Hotel Properties, LP to fund a por…

Energous Wireless Power Solutions Reports Second Quarter 2026 Results

Energous Wireless Power Solutions Reports Second Quarter 2026 Results

Energous Corporation announced strong financial results for Q2 2026, posting $3.1 million in revenue, a 217% increase year-over-year, marking its sixth consecutive quarter of revenue growth. The company secured FCC certification for its PowerBridge Pro+ product, enabling commercialization of its end-to-end wireless power solution for ambient IoT de…

Toppoint Holdings Inc. Reports Second Quarter 2026 Financial Results

Toppoint Holdings Inc. Reports Second Quarter 2026 Financial Results

Toppoint Holdings Inc. reported a 17% year-over-year revenue increase to $4.6 million in Q2 2026, an 80% reduction in net loss to $306,711, and a return to positive gross margin of 8%, driven by a strategic shift toward higher-value import and metal loads and price increases. The company completed a $4.15 million private placement, strengthened its…

MaxCyte Reports Second Quarter 2026 Financial Results

MaxCyte Reports Second Quarter 2026 Financial Results

MaxCyte, Inc. reported Q2 2026 total revenue of $7.3 million, with a net loss of $8.9 million, showing improvement from the prior year. The company reiterated its full-year 2026 revenue guidance of $30-32 million and highlighted a strategic multi-platform technology license partnership with Genentech announced post-quarter. Operating expenses decre…

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Aligos Therapeutics announced the successful dosing of the first participant in the Phase 1 clinical trial of ALG-170675, a next-generation antisense oligonucleotide aimed at functional cure for chronic hepatitis B virus infection. The study is being conducted in China by their partner Amoytop, who holds rights in Greater China. ALG-170675 has demo…

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts

Acrivon Therapeutics, a clinical-stage biotech company, announced its Q2 2026 financial results, highlighted progress in its lead clinical programs ACR-368 and ACR-2316 targeting endometrial and lung cancers, respectively, and provided upcoming milestones including interim data readouts and initiation of Phase 3 trials. The company also strengthene…

Core Molding Technologies to Host Investor Day on September 29-30, 2026, Including Tour of Matamoros, Mexico Manufacturing Facility

Core Molding Technologies to Host Investor Day on September 29-30, 2026, Including Tour of Matamoros, Mexico Manufacturing Facility

Core Molding Technologies, a leading engineered materials company specializing in molded structural products for various industries, announced an investor day event on September 29-30, 2026, including presentations and a tour of its large manufacturing facility in Matamoros, Mexico. Management will discuss growth opportunities, operational excellen…

Enovix Reports Second Quarter 2026 Results

Enovix Reports Second Quarter 2026 Results

Enovix Corporation reported Q2 2026 revenue of $9 million, up 21% year-over-year and at the high end of guidance, marking five consecutive quarters of growth. The company achieved its seventh consecutive quarter of positive gross profit amid increasing production scale. Key milestones include the lead smartphone customer confirming 1000+ battery cy…

ITG, Inc. Reports Second Quarter 2026 Results

ITG, Inc. Reports Second Quarter 2026 Results

ITG, Inc., a leading provider of digital infrastructure services, reported a 38% year-over-year revenue increase to $404.6 million and a 21% increase in adjusted EBITDA for Q2 2026. The company completed its IPO after the quarter and raised net proceeds mainly for debt repayment. ITG's substantial backlog and strong order activity, including broadb…

Lumexa Imaging Announces Second Quarter 2026 Results

Lumexa Imaging Announces Second Quarter 2026 Results

Lumexa Imaging announced its second quarter 2026 financial results, showing a 5.1% increase in consolidated revenues to $264.2 million and achieving net income of $2.7 million compared to a loss the previous year. The company highlighted advances including the opening of four new imaging centers and a new joint venture with Hospital for Special Sur…

SKYX Reports 14% Growth and Record Sales of $25.3 Million in Q-2 2026 Compared to $22.1 Million in Q-1 2026 and 10 Consecutive Quarters of Growth YoY and as It Continues to Grow Its Market Penetration

SKYX Reports 14% Growth and Record Sales of $25.3 Million in Q-2 2026 Compared to $22.1 Million in Q-1 2026 and 10 Consecutive Quarters of Growth YoY and as It Continues to Grow Its Market Penetration

SKYX Platforms Corp. announced strong Q2 2026 financial results with record sales of $25.3 million, representing 14% growth from Q1 2026 and 10 consecutive quarters of year-over-year revenue growth. The company improved gross profit and reduced net losses, supported by a better cash position of $27.7 million enabling plans to reach cash flow positi…